Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China State Council Lines Up Tasks In Five Key Healthcare Reforms

This article was originally published in PharmAsia News

Executive Summary

China's General Office of the State Council recently released the tasks identified for five key healthcare reforms in 2009: speed up establishment of a basic medical care system; set up a national essential drug system; improve the grassroots medical care service system; promote uniformity in basic public healthcare; and push for reform pilots in public hospitals. According to the line-up of requirements, the national essential drug list is to be finalized by the end of November, with all drugs included in the drug catalog of the national basic medical insurance. Public hospital reform pilots will be conducted in about 100 hospitals of 12 prefecture cities identified from the Eastern, Central and Western regions of China. The State Council task force, which leads the deepening of the healthcare reform, will inspect the overall implementation by year end. (Click here for more - Chinese language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072300

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel